Glioblastoma Clinical Trials in Long Beach, CA

View the best 10 glioblastoma medical studies in Long Beach, California. Access promising new therapies by applying to a Long Beach-based Glioblastoma clinical trial.

Trials in Long Beach, California

Here are the top 10 medical studies for glioblastoma in Long Beach, California

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2

This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.

Temozolomide +2 More

Alkylating Agent

Recruiting1 awardPhase 2

This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.

LP-184

Recruiting1 awardPhase 1 & 2

This trial will measure how safe and tolerable a drug is and test its effectiveness in treating advanced solid tumors.

Optune®

Device

Recruiting1 award12 criteria

This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.

Bevacizumab +2 More

Monoclonal Antibodies

Recruiting1 awardPhase 2

This trial is testing the safety and effectiveness of a combination treatment for subjects with recurrent or progressive GBM using N-803, PD-L1 t-haNK, and Bevacizumab.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2

This trial will study how well olaparib works in treating patients with certain types of cancer that have spread and usually cannot be controlled with treatment. Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2

This trial is testing a new drug called NGM707, both by itself and with another drug, Pembrolizumab. It targets patients with very advanced or spreading solid tumors. The treatment aims to boost the immune system to better fight cancer.

Atezolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2

This trial tests a combination of tocilizumab, atezolizumab, and precise radiation therapy in patients with recurrent glioblastoma. Tocilizumab reduces inflammation, atezolizumab boosts the immune system, and the radiation targets the tumor. The goal is to make the tumor more responsive to treatment and improve patient outcomes.

Temozolomide +1 More

Chemotherapy

Recruiting1 awardPhase 3

This trial is testing a treatment for newly diagnosed brain cancer patients. They are comparing the effectiveness of a new treatment called Optune with chemotherapy and immunotherapy to a combination of Optune with chemotherapy alone.

Selinexor +1 More

Selective Inhibitor of Nuclear Export

Recruiting1 awardPhase 1 & 2

This trial tests selinexor with temozolomide for patients whose brain cancer has returned. Selinexor blocks a protein that helps cancer cells grow, and temozolomide damages their DNA to kill them or stop their growth. Temozolomide is a DNA methylating drug currently used as a first-line treatment in glioblastoma therapy.

Popular Filters

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Conditions

Locations

Psychology Related

Treatments

Cities

Glioblastoma Clinical Trials in Long Beach, CA

Trials in Long Beach, California

BDTX-1535

Small Molecule Inhibitor

This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.

Temozolomide +2 More

Alkylating Agent

This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.

LP-184

This trial will measure how safe and tolerable a drug is and test its effectiveness in treating advanced solid tumors.

Optune®

Device

This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.

Bevacizumab +2 More

Monoclonal Antibodies

This trial is testing the safety and effectiveness of a combination treatment for subjects with recurrent or progressive GBM using N-803, PD-L1 t-haNK, and Bevacizumab.

Olaparib

PARP Inhibitor

This trial will study how well olaparib works in treating patients with certain types of cancer that have spread and usually cannot be controlled with treatment. Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Pembrolizumab +1 More

Monoclonal Antibodies

This trial is testing a new drug called NGM707, both by itself and with another drug, Pembrolizumab. It targets patients with very advanced or spreading solid tumors. The treatment aims to boost the immune system to better fight cancer.

Atezolizumab +1 More

Monoclonal Antibodies

Temozolomide +1 More

Chemotherapy

This trial is testing a treatment for newly diagnosed brain cancer patients. They are comparing the effectiveness of a new treatment called Optune with chemotherapy and immunotherapy to a combination of Optune with chemotherapy alone.

Selinexor +1 More

Selective Inhibitor of Nuclear Export

Popular Filters

Phase 3 Trials

Radiation

Personalized Immunotherapy for Glioblastoma

This trial will study an immunotherapy combining a cancer-patient's own cells and standard treatment to fight glioblastoma. Immune cells will be harvested from the patient, stimulated and expanded, then infused back.

Chemotherapy

Optune + Temozolomide + Pembrolizumab for Brain Cancer

This trial is testing a treatment for newly diagnosed brain cancer patients. They are comparing the effectiveness of a new treatment called Optune with chemotherapy and immunotherapy to a combination of Optune with chemotherapy alone.

Procedure

Advanced MRI Imaging for Glioblastoma

This trial is comparing a new type of MRI imaging called pH weighted chemical exchange saturation transfer (CEST) MRI to the standard MRI imaging for guiding surgical resections in patients with glioblastoma.

PARP Inhibitor

Niraparib vs Temozolomide for Brain Cancer

"This trial will compare two drugs, niraparib and temozolomide, to see which one is more effective for treating a specific type of brain cancer called glioblastoma. The

Alkylating agents

Lomustine + Standard Therapy for Glioblastoma

This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.

Alkylating agents

Multiple Therapies for Glioblastoma

This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.

Trials With No Placebo

Virus Therapy

NEO212 for Brain Tumors

This trial studies the safety and effectiveness of a drug to treat brain tumors and brain metastases. It has 3 phases and will assess safety, pharmacokinetics, and efficacy.

LP-184 for Solid Tumors

This trial will measure how safe and tolerable a drug is and test its effectiveness in treating advanced solid tumors.

Radiation

Personalized Immunotherapy for Glioblastoma

This trial will study an immunotherapy combining a cancer-patient's own cells and standard treatment to fight glioblastoma. Immune cells will be harvested from the patient, stimulated and expanded, then infused back.

CAR T-cell Therapy

Gene-Modified T Cell Therapy for Glioblastoma

This trial tests if a cell therapy can delay cancer return in GBM patients when combined with standard chemo. If it works, it should be studied further.

CAR T-cell Therapy

CAR T-Cell Therapy for Glioblastoma

This trial tests a new cancer treatment (CHM-1101) for glioblastoma to see if it is safe & effective.

Chemotherapy

Oral OKN-007 for Brain Tumor

This trial tests a drug to treat brain tumor in people, to see if it's safe, how it works, and how well it works.

View More Related Trials

View more glioblastoma clinical trials long-beach

Frequently Asked Questions

Other Trials to Consider

Anti-HER2/HER3 Dendritic Cell Vaccine

Macrodyne LivMD plate

Azacitidine

5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy

Eversense CGM System

Cisplatin

mFOLFIRINOX

5% nicotine

[18F]PI-2620